Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.00
Bid: 27.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 2.00 (7.407%)
Open: 28.00
High: 28.00
Low: 28.00
Prev. Close: 28.00
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investor presentation

6 Feb 2018 07:00

RNS Number : 9553D
Ilika plc
06 February 2018
 

 

Ilika plc

("Ilika" and the "Company")

 

Investor presentation

 

Ilika (AIM: IKA), pioneer in solid-state battery technology and materials innovation, announces that it will be presenting at the ShareSoc Growth Company Seminar in London on Tuesday 13 February.

 

ShareSoc is an organisation dedicated to supporting individual private shareholders ensuring that they have a voice and better access to information on the companies they invest in.

 

The event will commence at 5.30pm at the offices of Link Asset Services, 65 Gresham Street, London, EC2V 7NQ. At the event CEO Graeme Purdy and FD Steve Boydell will deliver a presentation detailing the Company's strategy followed by a Q&A session.

 

No new material information will be disclosed during the event.

 

If you are interested in attending the event and would like information on how to register please contact Walbrook PR at ilika@walbrookpr.com

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

Numis Securities Limited

Tel: 020 7260 1000

Paul Gillam /Oliver Cardigan/

James Black

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul Cornelius

Mob: 07866 384 707

Lianne Cawthorne

Mob: 07584 391 303

 

About Ilika

Ilika plc (AIM: IKA) pioneer in solid-state battery technology and materials innovation. The Company has been inventing new materials for energy and electronics markets for over a decade, including in automotive, aeronautical and electronic components sectors. Global brands such as Rolls Royce and Toyota collaborate with Ilika's development teams to create innovative products or improve the performance of existing components. By applying that heritage of patented materials invention, the Company has developed ground-breaking solid-state batteries to meet the specific demands of a wide range of applications in the Internet of Things (IoT). 

 

Ilika is now licensing its battery technology IP to partners for IoT sensors for the Smart Home/Building; Medical; Automotive and Transportation sectors around the world. Ilika's StereaxÒ  battery technology IP family offers compelling advantages over conventional lithium ion batteries, including: smaller footprint (energy density), non-toxic properties, faster charging, increased cycle life, low leakage and reduced flammability. Ilika is working to help build the connected world, removing the constraints of energy source for designers and engineers by delivering 'fit once and forget' power wherever it is needed. The Company is headquartered in the UK and has operations in the USA and Japan. Find more information at www.ilika.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRATAMITMBIMBIP
Date   Source Headline
27th Mar 20247:00 amRNSNotice of Capital Markets Day and Investor Q&A
23rd Jan 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNS2024 Conference Schedule
14th Dec 20231:46 pmRNSAward of Share Options, Exercise of Options & TVR
13th Dec 20231:43 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSLithium-ion parity development milestone
24th Nov 20237:00 amRNSTrading Update, Notice of Results & Presentations
20th Nov 20237:00 amRNSKey Technology Development Milestone
9th Oct 20237:00 amRNSAward of Scale-up Grant Funding for Goliath
20th Sep 20233:20 pmRNSResult of AGM & Award of Executive Share Options
18th Aug 20237:00 amRNSPosting of Annual Report and Notice of AGM
4th Aug 20237:00 amRNSSigned agreement with Cirtec Medical
13th Jul 20237:00 amRNSFinal Results
16th Jun 20237:00 amRNSSenior appointment&conversion of preference shares
22nd May 20237:00 amRNSTrading Update & Notice of Results
11th May 20237:00 amRNSFirst Customer Shipments of Stereax M300 Batteries
26th Apr 20237:00 amRNSExercise of Options and Total Voting Rights
11th Apr 20237:00 amRNSFirst Customer Shipment of Stereax® Batteries
8th Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSAward of Share Options
31st Jan 202310:30 amRNSDirector/PDMR Shareholding
30th Jan 20232:05 pmRNSSecond Price Monitoring Extn
30th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20232:05 pmRNSSecond Price Monitoring Extn
26th Jan 20232:00 pmRNSPrice Monitoring Extension
26th Jan 202311:05 amRNSSecond Price Monitoring Extn
26th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20239:05 amRNSSecond Price Monitoring Extn
26th Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSAward of Grant Funding for Goliath
19th Jan 20237:00 amRNSHalf-year Report
16th Jan 20237:00 amRNSMOU signed with Cirtec Medical
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
28th Dec 20224:40 pmRNSSecond Price Monitoring Extn
28th Dec 20224:35 pmRNSPrice Monitoring Extension
28th Dec 20222:05 pmRNSSecond Price Monitoring Extn
28th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
21st Nov 20221:29 pmEQSIlika 'well positioned' to deliver battery product combination
17th Nov 20224:40 pmRNSSecond Price Monitoring Extn
17th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20229:05 amRNSSecond Price Monitoring Extn
17th Nov 20229:00 amRNSPrice Monitoring Extension
17th Nov 20227:01 amRNSAppointment of Chief Financial Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.